-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
2010
February 12
The NORTHLAND NL003 project was selected as one of the Top Ten Enterprise Technological Innovation Achievements of Zhongguancun for 2009.
April 22nd
NORTHLAND was honored as the "Unit with Outstanding Contributions to the Industrialization of Major Scientific and Technological Achievements in 2009 in the Zhongguancun National Independent Innovation Demonstration Zone."
April 29
NL002 has completed Phase II clinical trials, and the Phase III clinical trial has received the “Notice of Acceptance of Drug Registration Application.”
August 20
The company has been selected as a key enterprise for the first batch of companies to be cultivated under the “Gazelle Program” of the Zhongguancun National Independent Innovation Demonstration Zone.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005